Translational Research and COVID Vaccine Successes: Perspectives from Industry, Venture and Government Agency

12:45 PM - 1:30 PM (EDT), Thursday, June 17, 2021
Search General Info
Search Education
Search Partnering Companies

In the era of COVID, research in vaccines and diagnostics aimed at stopping the spread of disease worldwide has seen breathtaking academic, corporate, and government mechanisms to quickly evaluate and adopt translational research platforms that have accelerated discovery to delivery in record time.
How these groundbreaking partnerships worked for the current challenge and how they may be applied in future challenges is the focus of this session. Speakers from a variety of public and industry sectors will review their current efforts showcasing their overarching objective to optimally and rapidly translate research efforts from advanced discovery to healthcare needs for a worldwide community.
Special focus on funding streams at each stage, encouragement of distinctive contributions by researchers, and transparent criteria on the current pathway for this and future pandemic events.

Managing Partner
Cambridge Innovation Partners